Skip links and keyboard navigation

PAH leads trial pioneering new standard of care

16 June 2017

Princess Alexandra Hospital’s (PAH) Professor Sandro Porceddu has headed a new trial, which showed patients with advanced skin cancer can now be spared from having to undergo chemotherapy as surgery combined with radiotherapy was a more effective treatment.

The TROG Cancer Research ‘POST’ trial showed that for patients with advanced squamous cell carcinoma (one of the most common forms of skin cancer) of the head and neck, surgery and post-operative radiotherapy resulted in high cure rates, in excess of 85 per cent.

“The trial also showed that the addition of chemotherapy did not improve cure rates. This will save patients from the added side effects associated with chemotherapy,” Prof Porceddu said.

Prof Porceddu presented the results of the TROG Cancer Research trial to more than 1,000 international medical professionals at the prestigious American Society of Clinical Oncology (ASCO) Meeting in the US last week.

“We should be proud of our achievements on the world stage and presenting these results to the ASCO 2017 conference demonstrates that our research is world class,” Prof Porceddu said.

More than 320 patients from 23 hospitals and cancer centres from Australia and New Zealand took part in the 11-year trial, which began in 2005.

Robert Schampers was diagnosed with squamous cell carcinoma of the neck in August 2012. He was happy to be part of the ‘POST’ trial at PAH, and had radiation, chemotherapy and surgery.

The 57-year-old roof plumber said he found a lump on his neck one day driving home from work.

“I went for a CT scan and within a week had surgery. The doctors were very confident they got it all but I had radiation and chemotherapy as well just to be safe,” Mr Schampers said.

“‘Whatever I need, just give it to me’ I said to the doctors.”

Despite being diagnosed with bowel cancer approximately one year after his skin cancer treatment, Mr Schampers said he feels reasonably good and was lucky to be part of the trial.

“I’m a big believer that helping someone else is a good thing,” he said.

Last updated 16 June 2017
Last reviewed 16 June 2017

Other news

Bowel cancer early detection is key

Bowel Cancer—early detection is key

Bowel cancer is Australia’s second biggest cancer killer but is one of the most treatable types if found early. This Bowel Cancer Awareness Month Princess Alexandra Hospital Health Promotion Officer Abby Fraser was encouraging the community to ‘Make No. 2 your No. 1 priority’ and participate in the free National Bowel Cancer Screening Program.

Dr Darshan Shah clot dissolving drug trial for stroke patients

Trial tests time-saving clot-dissolving drug

A clot-dissolving drug trial could see stroke patients receive life-saving treatment faster. The Princess Alexandra Hospital Stroke Unit was participating in a trial that aimed to show Tenecteplase, a clot-dissolving drug currently used in heart attack patients, could reduce treatment time for stroke patients by an hour.